SI1333833T1 - Novel trisubstituted-8H-pyrido?á2,3-d?åpyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases - Google Patents

Novel trisubstituted-8H-pyrido?á2,3-d?åpyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases

Info

Publication number
SI1333833T1
SI1333833T1 SI200131005T SI200131005T SI1333833T1 SI 1333833 T1 SI1333833 T1 SI 1333833T1 SI 200131005 T SI200131005 T SI 200131005T SI 200131005 T SI200131005 T SI 200131005T SI 1333833 T1 SI1333833 T1 SI 1333833T1
Authority
SI
Slovenia
Prior art keywords
åpyrimidin
csbp
pyrido
compound
treatment
Prior art date
Application number
SI200131005T
Other languages
Slovenian (sl)
Inventor
Jerry L Adams
Jeffrey C Boehm
Ralph Hall
Qi Jin
Jiri Kasparec
Domingos J Silva
John J Taggart
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Priority claimed from EP01994463A external-priority patent/EP1333833B1/en
Publication of SI1333833T1 publication Critical patent/SI1333833T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200131005T 2000-10-23 2001-10-23 Novel trisubstituted-8H-pyrido?á2,3-d?åpyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases SI1333833T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24246100P 2000-10-23 2000-10-23
US31034901P 2001-08-06 2001-08-06
US32661801P 2001-10-02 2001-10-02
EP01994463A EP1333833B1 (en) 2000-10-23 2001-10-23 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
PCT/US2001/050493 WO2002059083A2 (en) 2000-10-23 2001-10-23 Novel compounds

Publications (1)

Publication Number Publication Date
SI1333833T1 true SI1333833T1 (en) 2011-12-30

Family

ID=38812518

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200131005T SI1333833T1 (en) 2000-10-23 2001-10-23 Novel trisubstituted-8H-pyrido?á2,3-d?åpyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases

Country Status (6)

Country Link
AR (1) AR035592A1 (en)
MY (1) MY145907A (en)
PE (1) PE20020513A1 (en)
SI (1) SI1333833T1 (en)
TW (2) TWI298722B (en)
UY (1) UY26980A1 (en)

Also Published As

Publication number Publication date
TWI331149B (en) 2010-10-01
TWI298722B (en) 2008-07-11
UY26980A1 (en) 2002-06-20
PE20020513A1 (en) 2002-08-24
TW200815433A (en) 2008-04-01
MY145907A (en) 2012-05-15
AR035592A1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
MXPA03006250A (en) Therapeutic heterocyclic compounds.
HK1059562A1 (en) Novel trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of csbp/p38 kinase mediated diseases
IL150432A0 (en) Process for the epoxidation of olefins
MXPA03008041A (en) Process for the manufacture of moldings.
EG22541A (en) Process for the production of olefins
EP1442062A4 (en) Methods for the treatment of carcinoma
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
MXPA03008205A (en) Process for the preparation of imidazole compounds.
IL154624A (en) Bicyclic heteroaromatic compounds
MXPA02006102A (en) Process for the preparation of bromodifluoroacetic compounds.
AU2002358469A8 (en) Modified receptors for the discovery of therapeutic ligands
MXPA03006606A (en) Process for the preparation of heterocyclic indene analogs.
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
MXPA03001472A (en) Compounds for the treatment of addictive disorders.
PL373627A1 (en) Process for the preparation of melamine
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
SI1333833T1 (en) Novel trisubstituted-8H-pyrido?á2,3-d?åpyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
MXPA03009210A (en) New process for the preparation of oxabispidines.
EG23229A (en) Process for the production of olefins.
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
HK1051190A1 (en) Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds.
AU2002331162A8 (en) Human serine/threonine kinase
PL374911A1 (en) Process for the preparation of zaleplon
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol
HK1071358A1 (en) Process for the preparation of 5-formylphthalide